Westlake Village BioPartners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Vedana Therapeutics, Inc.vedanatx.comSeries A · Jun 2026 · $46M
Vedana Therapeutics develops next-generation biologic medicines for migraine prevention, targeting PACAP and CGRP-independent pathways to address unmet needs in patients inadequately controlled by current therapies.
BiotechHealthtechMedical Devices
Co-investorsCanaan Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.